Trisalus Life Sciences Inc Share Price

NASDAQ: TLSI

Small Cap

$4.73

+0.13

(+2.83%)

as on September 17, 2025 at 1:29 am IST

$₹

Trisalus Life Sciences Inc Stock Performance

as on September 17, 2025 at 1:29 am IST

Day's Low
Day's High
$4.51
Day's Price Range
$4.76
$4.73
4.65%
Downside
0.63%
Upside
52 Week's Low
52 Week's High
$3.42
52-Week Price Range
$5.88
$4.73
27.70%
Downside
24.31%
Upside

Trisalus Life Sciences Inc share price movements today

Previous Close: $4.60
Open: $4.65
Volume: 436.4K
Day's Low - High: $4.51 - $4.76
52 Week Low - High: $3.42 - $5.88

Trisalus Life Sciences Inc Historical Returns

1 Month Return: + 1.1 %
3 Month Return: -16.52 %
1 Year Return: -1.5 %
3 Year Return: 0 %
5 Year Return: 0 %

Trisalus Life Sciences Inc Stock Fundamentals & Key Indicators

Check Trisalus Life Sciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$229.4M

EPS (TTM)

-0.79

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-30.3M

Revenue (TTM)

36.0M

Profit Margin

-86.61%

Return On Equity TTM

28266600.00%

Trisalus Life Sciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Trisalus Life Sciences Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Trisalus Life Sciences Inc	BUY	$229.4M	NA	NA	-86.61%
Boston Scientific Corp.	BUY	$152.2B	148.49%	60.9	13.55%
Stryker Corporation	BUY	$146.6B	74.74%	50.76	12.25%
Abbott Laboratories	BUY	$232.8B	24.25%	16.77	32.43%
Medtronic Plc	BUY	$120.6B	-13.08%	25.95	13.63%

See all

Stock Returns calculator for Trisalus Life Sciences Inc Stock including INR - Dollar returns

The Trisalus Life Sciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Trisalus Life Sciences Inc investment value today

Current value as on today

₹1,06,152

Returns

₹6,152

(+6.15%)

Returns from Trisalus Life Sciences Inc Stock

₹1,285 (+1.28%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Trisalus Life Sciences Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Trisalus Life Sciences Inc. Average target price of $11.31

Trisalus Life Sciences Inc Share Price Target

Get share price movements and forecasts by analysts on Trisalus Life Sciences Inc.

What analysts predicted

58.18%UPSIDE

Target Price

$11.31

Current Price

$4.73

Analyzed by

7 Analysts

Target

$11.31

Trisalus Life Sciences Inc target price $11.31, a slight upside of 58.18% compared to current price of $4.73. According to 7 analysts rating.

Trisalus Life Sciences Inc Stock's Interest Amongst Investors

Search interest for Trisalus Life Sciences Inc Stock has increased by 33% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:33% versus previous 30 day period

Trisalus Life Sciences Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	2	4	5	5	6	7	7	8	9	11
Gross Profit	2	3	4	5	5	6	6	7	7	9
Operating Income	-10	-11	-18	-14	-11	-8	-8	-7	-7	-7
EBITDA	-9	-11	0	-35	-13	-3	-1	-	-8	-6
Interest Expense	0	0	0	0	0	0	1	1	1	1
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-8	-13	-1	-35	-13	-4	-2	-10	-10	-8
Income Tax Expense	0	0	0	0	0	0	0	-	0	0
Net Income	-8	-13	-1	-35	-13	-4	-2	-10	-10	-8
Net Profit Margin	-277.08%	-302.99%	-24.76%	-620.68%	-204.72%	-58.83%	-32.64%	-122.36%	-113.18%	-73.91%

Trisalus Life Sciences Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	8	12	18	29
Gross Profit	7	10	15	25
Operating Income	-24	-36	-54	-36
EBITDA	-23	-46	-58	-36
Interest Expense	1	0	0	3
Depreciation	0	0	0	0
Income Before Tax	-28	-47	-59	-30
Income Tax Expense	0	0	0	0
Net Income	-28	-47	-59	-33
Net Profit Margin	-343.35%	-380.60%	-318.93%	-112.92%

Trisalus Life Sciences Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-13	-1	-35	-13	-4	-2	-10	-10	-8
Operating Cash Flow	-9	-21	-8	-10	-13	-10	-5	-4	-7
Investing Cash Flow	0	-1	0	0	0	0	-	0	0
Financing Cash Flow	6	40	0	3	25	5	2	9	20
Change in Cash	-2	17	-9	-7	12	-5	-2	4	13

Trisalus Life Sciences Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-28	-47	-59	-30
Operating Cash Flow	-22	-32	-50	-40
Investing Cash Flow	-2	-1	-2	0
Financing Cash Flow	50	13	54	37
Change in Cash	25	-20	2	-3

Insights on Trisalus Life Sciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -10.37M → -8.28M (in $), with an average increase of 25.2% per quarter
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 4 quarters, 7.34M → 11.21M (in $), with an average increase of 13.1% per quarter
NO EFFECT
Against Peers
In the last 3 years, Boston Scientific Corp. has given 139.5% return, outperforming this stock by 193.1%
NO EFFECT
Against Peers
In the last 1 year, Boston Scientific Corp. has given 21.0% return, outperforming this stock by 22.3%
NEGATIVE IMPACT
Price Dip
In the last 7 days, TLSI stock has moved down by -2.7%

About Trisalus Life Sciences Inc

TriSalus Life Sciences, Inc. is an oncology-focused medical technology company. The Company is seeking to transform outcomes for patients with solid tumors by integrating its delivery technology with standard-of-care therapies, and with its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 agonist, for a range of different therapeutic and technology applications. The Company’s platform includes devices that utilize a proprietary drug delivery technology and a clinical-stage investigational immunotherapy. The Company’s two Food and Drug Administration (FDA)-cleared devices use its proprietary Pressure-Enabled Drug Delivery (PEDD) approach to deliver a range of therapeutics: the TriNav Infusion System for hepatic arterial infusion of liver tumors and the Pancreatic Retrograde Venous Infusion System for pancreatic tumors. PEDD technology is a novel delivery approach designed to address the anatomic limitations of arterial infusion for the pancreas.

Organisation	Trisalus Life Sciences Inc
Headquarters	6272 West 91st Avenue, Westminster, CO, United States, 80031
CEO	Ms. Mary T. Szela B.S.N., M.B.A.
E-voting on shares	Click here to vote

Key Management of Trisalus Life Sciences Inc

Name	Title
Ms. Mary T. Szela B.S.N., M.B.A.	CEO, President & Director
Ms. Jodi Devlin	Chief of Clinical Strategy & Operations
Mr. David B. Patience	Chief Financial Officer
Ms. Lori Ann Santamaria	Vice President of Operations
Ms. Jennifer L. Stevens J.D.	Chief Regulatory Officer
Dr. Richard B. Marshak M.B.A., MBA, VMD	Chief Commercial Officer
Dr. Bryan F. Cox Ph.D.	Chief of Research
Mr. James E. Young	Secretary & Treasurer

FAQs

What is Trisalus Life Sciences Inc share price today?

Trisalus Life Sciences Inc share price today is $4.73 as on September 17, 2025 at 1:29 am IST at the close of the market. Trisalus Life Sciences Inc share today touched a day high of $4.76 and a low of $4.51.

What is the 52 week high and 52 week low for Trisalus Life Sciences Inc share?

Trisalus Life Sciences Inc share touched a 52 week high of $5.88 on April 29, 2025 and a 52 week low of $3.42 on August 12, 2025. Trisalus Life Sciences Inc stock price today i.e. September 17, 2025 at 1:29 am IST is closed at $4.73,which is 19.56% down from its 52 week high and 38.30% up from its 52 week low.

What is Trisalus Life Sciences Inc's market capitalisation today?

Trisalus Life Sciences Inc market capitalisation is $0.00T as on September 17, 2025 at 1:29 am IST.

How to invest in Trisalus Life Sciences Inc Stock (TLSI) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Trisalus Life Sciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Trisalus Life Sciences Inc Shares that will get you 0.3171 shares as per Trisalus Life Sciences Inc share price of $4.73 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Trisalus Life Sciences Inc Stock (TLSI) from India?

Indian investors can start investing in Trisalus Life Sciences Inc (TLSI) shares with as little as ₹88.042 or $1 (as of September 17, 2025 at 11:44 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Trisalus Life Sciences Inc stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 11:44 am IST). Based on Trisalus Life Sciences Inc share’s latest price of $4.73 as on September 17, 2025 at 1:29 am IST, you will get 2.1142 shares of Trisalus Life Sciences Inc. Learn more about fractional shares .